Catalyst Wire Dossier Catalyst Wire Dossier

Birch pollen sublingual immunotherapy solution

birch pollen extract · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Birch pollen sublingual immunotherapy solution, covering 2012-11-27 to 2012-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis [Phase 3]

See pricing